title: Parenteral administration of tobramycin for pulmonary exacerbations in cystic fibrosis patients: toxicity, serum levels and efficacy.
authors.affiliation: Deparment of Pediatrics, University of Florence, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Braccini
authors.forename: I
authors.initials: I
authors.lastname: Lori
authors.forename: A S
authors.initials: AS
authors.lastname: Neri
authors.forename: F
authors.initials: F
authors.lastname: Festini
authors.forename: I
authors.initials: I
authors.lastname: Pela
authors.forename: R
authors.initials: R
authors.lastname: Ciuti
authors.forename: V
authors.initials: V
authors.lastname: Boni
authors.forename: L
authors.initials: L
authors.lastname: Zavataro
authors.forename: C
authors.initials: C
authors.lastname: Braggion
authors.forename: M
authors.initials: M
authors.lastname: De Martino
authors.forename: G
authors.initials: G
authors.lastname: Taccetti
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects* / Q000097:blood; D002648:Child; D003051:Cochlea / Q000187:drug effects; D003550:Cystic Fibrosis / Q000150:complications / Q000188:drug therapy*; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy* / Q000209:etiology; D034381:Hearing Loss / Q000139:chemically induced; D006801:Humans; D007263:Infusions, Parenteral; D007668:Kidney / Q000187:drug effects; D008297:Male; D014031:Tobramycin / Q000008:administration & dosage* / Q000009:adverse effects* / Q000097:blood
chemical_list: D000900:Anti-Bacterial Agents; D014031:Tobramycin